Abstract
Advances in science and technology have led to an explosive growth in diagnostic, therapeutic, preventive, and rehabilitative methodologies in health care during the second half of the twentieth century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Goldschlager N (1988) Permanent cardiac pacing for brady-arrhythmia. Postgrad Med 83:156–174.
Serwer GA, Mericle JM (1987) Evaluation of pacemaker pulse generator and patient longevity in patients aged 1 day to 20 years. Am J Cardiol 59: 824–827.
Parsonnet V, Berstein AD, Perry GY (1990) The nuclear pacemaker: is renewed interest warranted? Am J Cardiol 66: 837–842.
Kadish A, Calkins H, de-Buitleir M, Morady F (1990) Feasibility and cost savings of outpatient electrophysiologic testing. J Am Coll Cardiol 16:1415–1419.
Lezaun R, Brugada P, Smeets J, et al. (1989). Cost-benefit analysis of medical vs surgical treatment of symptomatic patients with accessory atrioventricular pathways. Eur Heart J 10:1105–1109.
Gallagher JJ, Selle JG, Sevenson RH, et al. (1988) Surgical treatment of arrhythmias. Am J Cardiol 61:27A–44A.
Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JT, Ruskin JN (1990) An analysis of the cost effectiveness of the implantable defibrillator. Circulation 81: 91–100.
Kay GN, Plumb VJ, Dailey SM, Epstein AE (1990) Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias. Am J Med 88: 25H-34N.
Winkle RA, Mead RH, Ruder MA, Smith NA, Buch WS, Gaudiani VA (1990) Effect of duration of ventricular fibrillation of defibrillation efficacy in humans. Circulation 81: 1477–1481.
Kalbfleisch KR, Lehmann MH, Steinman RT, et al. (1989) Reemployment following implantation of the automatic cardioverter defibrillator. Am J Cardiol 64:199–202.
O’Donoghue S, Platia EV, Brooks-Robinson S, Mispireta L (1990) Automatic implantable cardioverter-defibrillator: is early implantation cost-effective? J Am Coll Cardiol 16: 1258–1263.
van den Oever R (1986) The impact of health technology on funds, pp. 47–56 in Proceedings of IFVHSF Conference, 1986. London: International Federation of Voluntary Health Service Funds.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
van den Oever, R. (1992). Arrhythmia technology. The insurer’s point of view. In: Andries, E., Brugada, P., Stroobandt, R. (eds) How to face ‘the faces’ of Cardiac Pacing. Developments in Cardiovascular Medicine, vol 129. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2582-6_16
Download citation
DOI: https://doi.org/10.1007/978-94-011-2582-6_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5139-2
Online ISBN: 978-94-011-2582-6
eBook Packages: Springer Book Archive